New course empowers students to address diversity in STEM

The seminar explores the ways in which women, people of color and others have been marginalized in science, technology, engineering and mathematics and how to address exclusion.

Cell-free biotech enables shelf-stable vaccines on demand

Researchers devised a new method of using extracts to create shelf-stable vaccines on demand, a potentially game-changing approach to fighting infection in regions that have limited access to such medicines.

Score! Engineering startup wins NFL innovation competition

Cornell Engineering startup Organic Robotics Corporation and its stretchable sensing technology, Light Lace, topped a field of four finalists to win the sixth annual NFL 1st & Future competition, sponsored by the National Football League.

Dimensional Energy emerges as $20M Carbon X Prize finalist

Dimensional Energy – a McGovern Center startup that converts carbon dioxide via sunshine into eco-friendly aviation fuel – is a finalist for the $20 million Carbon X Prize.

Global ‘wind atlas’ propels sustainable energy

Cornell wind energy scientists have released a new global wind atlas – a digital compendium filled with documented extreme wind speeds – to improve turbine placement.

Cornell startup to compete in NFL innovation competition

Organic Robotics Corporation, a Cornell engineering startup founded in 2018, is in the finals the sixth annual NFL 1st & Future competition, airing Feb. 2 at 8 p.m. EST on the NFL Network.

COVID-19 research seed grants yielding rapid results

Professor Iwijn De Vlaminck is working on using cell-free DNA – discarded scraps of DNA – as a way of gaining understanding of COVID-19’s effects on the organs of children who've been exposed to the SARS-CoV-2 virus.

Model makers: How engineers saved the fall, spring semesters

As the spring semester begins, a team of engineering students and faculty has finished tweaking the master schedule, using lessons they learned last fall during their heroic effort to help Cornell safely hold in-person classes.

Noninvasive blood test tracks organ injury from COVID-19

A Cornell-led collaboration has developed a noninvasive blood test that uses cell-free DNA to gauge the damage that COVID-19 inflicts on cells, tissues and organs, and could help aid in the development of new therapies.